XML 165 R7.htm IDEA: XBRL DOCUMENT v3.20.4
Consolidated Statements of Shareholders' Equity (Deficit) - USD ($)
shares in Thousands, $ in Thousands
Total
Ordinary shares
Preferred Stock
Additional paid-in capital
Accumulated deficit
Accumulated other comprehensive loss
Treasury Shares
Beginning balance (in shares) at Dec. 31, 2017   41,463 0       2,117
Beginning balance at Dec. 31, 2017 $ 85,580 $ 414 $ 0 $ 393,478 $ (262,685) $ (23,266) $ (22,361)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income (loss) (95,304)       (95,304)    
Other comprehensive income (loss) (150)         (150)  
Exercise of stock options (in shares)   82          
Exercise of stock options 535 $ 1   534      
Exercise of warrants (in shares)   603          
Exercise of warrants 2,911 $ 6   2,905      
Expiration of warrants 2,167     2,167      
Vesting of restricted shares (in shares)   547          
Vesting of restricted shares 0 $ 6   (6)      
Employee share purchase plan share issuance (in shares)   25          
Employee share purchase plan share issuance 127     127      
Share-based compensation expense 7,852     7,852      
Equity component of 2023 Notes 26,699     26,699      
Share repurchases (in shares)             3,290
Share repurchases (27,637)           $ (27,637)
Ending balance (in shares) at Dec. 31, 2018   42,720 0       5,407
Ending balance at Dec. 31, 2018 2,780 $ 427 $ 0 433,756 (357,989) (23,416) $ (49,998)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income (loss) (33,226)       (33,226)    
Other comprehensive income (loss) 610         610  
Vesting of restricted shares (in shares)   153          
Vesting of restricted shares 0 $ 2   (2)      
Employee share purchase plan share issuance (in shares)   54          
Employee share purchase plan share issuance 118     118      
Share-based compensation expense 519     519      
Ending balance (in shares) at Dec. 31, 2019   42,927 0       5,407
Ending balance at Dec. 31, 2019 (29,199) $ 429 $ 0 434,391 (391,215) (22,806) $ (49,998)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income (loss) 7,028       7,028    
Other comprehensive income (loss) $ 1,755         1,755  
Exercise of stock options (in shares) 403 403          
Exercise of stock options $ 2,045 $ 4   2,041      
February 2020 private placement (in shares)   8,680 488        
February 2020 private placement 60,570 $ 87 $ 5 60,478      
May 2020 public offering (in shares)   11,630          
May 2020 public offering 116,924 $ 116   116,808      
Vesting of restricted shares (in shares)   114          
Vesting of restricted shares 0 $ 1   (1)      
Employee share purchase plan share issuance (in shares)   49          
Employee share purchase plan share issuance 144     144      
Share-based compensation expense 2,999     2,999      
Retirement of treasury shares (in shares)   (5,407)         (5,407)
Retirement of treasury shares 0 $ (54)   (49,944)     $ (49,998)
Ending balance (in shares) at Dec. 31, 2020   58,396 488       0
Ending balance at Dec. 31, 2020 $ 162,266 $ 583 $ 5 $ 566,916 $ (384,187) $ (21,051) $ 0